Immunetrics is a bio-simulation company on the cutting edge of in silico modeling. The Company's modeling technology provides critical information to accelerate and improve drug discovery and development.

The power of predictive models is obvious in many industries, from aircraft and automotive design to supply-chain optimization. Working with pharmaceutical clients and global thought leaders, Immunetrics brings the power of computational modeling to biomarker development, preclinical experiment design, lead selection, and clinical trial design. This reduces risk while speeding the critical path to approval.

This is not statistical modeling. Immunetrics builds bottom-up predictive models based on biological pathways spanning the molecular, cellular, organ, organism, and population scales. We collaborate with our customers to provide proprietary models for their exclusive use. Please read more about our technology or contact us today for more information.

Current Updates:

THE MODELING PLATFORM AND MODELING SERVICES FOR ACUTE ILLNESSES IS NOW AVAILABLE FOR ACADEMIC AND COMMERCIAL LICENSING Contact us for more details
In the News: Pitt gets grant to create spinal cord center (Link)
Immunetrics Inc. Extends In Silico Modeling Collaboration With Lilly — August 30, 2006 (Link)
Shock 2006 Conference poster (Link)
Immunetrics and Lilly to Apply In Silico Modeling Technology to Trial Design — September 6, 2005 (Link)
Critical Care Medicine publication (Link)
Immunetrics is hiring! Visit our careers section for available positions.

Upcoming Key Events:


more details

© 2007 Immunetrics